| Dr Ji Yon Han, MD | |
|
4902 Irvine Center Dr Ste 102, Irvine, CA 92604-3334 | |
| (949) 757-3690 | |
| (949) 596-9146 |
| Full Name | Dr Ji Yon Han |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 4902 Irvine Center Dr Ste 102, Irvine, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285858274 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | A108338 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ji Yon Han, MD 4902 Irvine Center Dr Ste 102, Irvine, CA 92604-3334 Ph: (949) 757-3690 | Dr Ji Yon Han, MD 4902 Irvine Center Dr Ste 102, Irvine, CA 92604-3334 Ph: (949) 757-3690 |
News Archive
The National Coalition for Cancer Survivorship announced its support of the two final rules issued by the Centers for Medicare and Medicaid Services and the Office of the National Coordinator for Health Information Technology for the electronic health record incentive programs at a briefing hosted by the U.S. Department of Health and Human Services today.
Bill Gates, co-founder of the Bill & Melinda Gates Foundation, and Carlos Slim, the "Mexican telecom magnate" and founder of the Carlos Slim Institute, announced Monday that they would work with Spain on a $150 million health initiative for people in Central America and Mexico, Agence France-Presse reports.
Researchers at The University of Texas MD Anderson Cancer Center have discovered mutations that may fuel early cancer growth in precancerous colorectal tissue from high-risk patients.
World Polio day is observed on the 24th of October. This year on the day officials announced that one of the three strains of the wild polio virus has been finally wiped out due to persistent vaccination efforts across the globe.
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, announces the final data from the ENTRANCE Phase IIa trial in inflammatory bowel disease with vidofludimus, an oral inhibitor of interleukin-17 release and DHODH, including the secondary endpoints comprising the analysis of CDAI and CAI disease scores, change of prednisolone intake and threshold doses, safety, pharmacokinetics and biomarkers.
› Verified 7 days ago
Dr. Marnie Baker, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4050 Barranca Pkwy Ste 170, Irvine, CA 92604 Phone: 949-551-1090 Fax: 949-262-5500 | |
Dr. Manpreet Kaur Sarna, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 18 Endeavor Ste 101, Irvine, CA 92618 Phone: 949-509-9915 Fax: 949-509-1116 | |
Jeffrey G Lobas, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 313 Tall Oak, Irvine, CA 92603 Phone: 480-789-1819 | |
Dr. Neerja Tina Zand, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 55 Ashford, Irvine, CA 92618 Phone: 949-786-0414 | |
Dr. Daniel Joseph Otterson, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Medical Plaza Drive, Irvine, CA 92697 Phone: 949-824-8600 | |
Dr. Grady B Huckaby Jr., MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4050 Barranca Pkwy, Suite 270, Irvine, CA 92604 Phone: 949-559-5601 Fax: 949-559-7115 | |
Dr. Renee Stein, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 81 Linhaven, Irvine, CA 92602 Phone: 714-368-0655 |